Filing Flows › Castle Biosciences (CSTL) › Stock forecast & fair value
Castle Biosciences (CSTL) stock forecast and price target
Castle Biosciences (CSTL) trades at $32.52. 10 analysts' median price target is $46.00 (+41%), from $35.00 to $60.00.
Castle Biosciences' latest quarter
Castle Biosciences, Q3 2026: revenue $103M (+24% year over year), operating margin -2.7%, net loss $4.1M, operating cash flow $19.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for CSTL stock?
The median of 10 analysts' 12-month targets is $46.00, +41% from $32.52; the range is $35.00 to $60.00. The average rating is strong buy.
Does Castle Biosciences usually beat earnings estimates?
It beat the consensus EPS estimate in 80% of the quarters on record.
Is CSTL stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.